Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000103

Drug Information
Synonyms4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidine; Ciproheptadina; Viternum; HSDB 3048; nchembio.559-comp10; CHEMBL516; Cyproheptadine (INN); NCGC00015252-03; AKOS004119847; Prestwick3_000103; Cyproheptadinum; Prestwick1_000103; Ciproheptadina [INN-Spanish]; Prestwick0_000103; BPBio1_000096; 5-20-08-00500 (Beilstein Handbook Reference); Tocris-0996; BRD-K28143534-003-03-6; BRN 1685976; L001016; Piperidine, 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methyl-; Lopac0_000246; CCRIS 5232; 4-(5-Dibenzo(a,d)cyclohepten-5-ylidine)-1-methylpiperidine; SPBio_002025; Cyproheptadine [INN:BAN]; Cypoheptadine; HMS2090P20; NCGC00024293-02; C06935; NCGC00015252-02; MK 141; 1-Methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine; DB00434; Dronactin; D07765; Ciprovit (TN); CHEBI:4046; NCGC00024293-05; MolPort-002-507-777; PDSP2_001213; UNII-2YHB6175DO; EINECS 204-928-9; Eiproheptadine; Biomol-NT_000131; STK802098; 4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine; CYPROHEPTADINE; PDSP1_001229; Prestwick2_000103; BPBio1_000155; Dihexazin; NCGC00015252-09; Cyproheptadine Hcl; Oprea1_498140; 129-03-3; AC1L1ER8; 4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidene; 41354-29-4; BRD-K28143534-001-01-4; Dibenzosuberonone/Cyproheptadine; Lopac-C-6022; Periactin; Ciprovit; Piperidine, 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-methyl-; BIDD:GT0324; CAS-969-33-5; Cyproheptadiene; 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine; 5-(1-Methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene; LS-114933; Periactinol; CID2913; Periactine; 1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine; BSPBio_000086; Cyproheptadinum [INN-Latin]; NCGC00024293-04; NCGC00015252-01    
Trade NamePeriactin    
CompanyMerck & Co    
IndicationAllergiesApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAntihistamines    
CAS NumberCAS 129-03-3
PubChem Compound IDCID 2913.    
PubChem Substance IDSID 9151.    
SuperDrug ATC IDA15AA01;    
SuperDrug CAS ID000129033;    
TargetHistamine H1 receptorAntagonist[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 040537 To Reference
Ref 2Cyproheptadine displays preclinical activity in myeloma and leukemia. Blood. 2008 Aug 1;112(3):760-9. Epub 2008 May 23. To Reference
Ref 3Antihistamines in the treatment of dermatitis. J Cutan Med Surg. 2003 Nov-Dec;7(6):467-73. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543